Table 1. Anthropometrics of Study 2 cohort.
Data are shown as mean for each group with the interquartile range in parentheses.
Study group | Lean | Obese |
---|---|---|
Age (years) | 52.1 (32.5–64.6) | 41.6 (31.3–51.9) |
BMI (kg/m2) | 26.2 (24–28.8) | 45.1 (41.8–49.7) |
Triglycerides (mmol/l) | 0.8 (0.6–03.5) | 5.3 (0.6–6.6) |
Height (m) | 1.7 (1.6–1.8) | 1.7 (1.7–1.8) |
Body weight (kg) | 75.5 (67.9–83) | 135.6 (117.9–150) |
BMI (kg/m2) | 26.2 (24–28.8) | 45.1 (41.8–49.7) |
Body fat (%) | 30.9 (23.1–38.6) | 46 (41.3–48.9) |
Hemoglobin (mmol/l) | 8.3 (7.9–8.9) | 8.3 (7.9–8.9) |
Erythrocytes (exp12/l) | 4.6 (4.3–4.8) | 4.7 (4.5–4.9) |
Thrombocytes (exp9/l) | 259 (230.3–294) | 285.5 (244.5–320.3) |
Leukocytes (exp9/l) | 6.6 (5.5–8) | 7.7 (6.4–8.8) |
ALAT (μkat/l) | 0.4 (0.3–0.5) | 0.5 (0.4–0.6) |
ASAT (μkat/l) | 0.5 (0.4–0.5) | 0.5 (0.4–0.6) |
gGT (μkat/l) | 0.7 (0.3–0.7) | 0.7 (0.3–1.1) |
Fasting plasma glucose (mmol/l) | 5.3 (4.8–5.9) | 5.8 (5.2–7.8) |
HbA1c (%) | 5.6 (5.4–6) | 5.8 (5.3–6.6) |
Fasting plasma insulin (pmol/l) | 31.3 (15.9–83.5) | 143.5 (79.2–185.4) |
C-Peptid (nmol/l) | 1 (0.7–1.3) | 1.4 (0.9–2) |
Creatinine (μmol/l) | 76 (59–85) | 67.5 (56.8–79.3) |
Cholesterol total (mmol/l) | 5.5 (4.5–6.4) | 4.9 (4.3–5.3) |
HDL-Cholesterol (mmol/l) | 1.3 (1.1–1.8) | 1.1 (0.9–1.5) |
LDL-Cholesterol (mmol/l) | 3.1 (2.4–3.9) | 2.6 (2.1–2.9) |
Total protein (g/l) | 72.3 (69.8–78) | 75.6 (73.2–84.1) |
Albumin (g/l) | 45.9 (44.4–46.8) | 45.5 (43.6–46.7) |
TSH (mU/l) | 1.5 (0.9–2) | 2.1 (1.4–3.3) |
fT3 (pmol/l) | 4.8 (4.3–5.2) | 4.5 (4.3–5.3) |
fT4 (pmol/l) | 15.7 (14–17.1) | 13.8 (13–15.6) |
Cortisol (nmol/l) | 354 (212.9–549.7) | 396.3 (302.8–500.8) |
Testosteron (nmol/l) | 1.1 (0.5–9) | 1.4 (0.9–5.5) |
RRsys (mmHg) | 131 (124.3–139.3) | 143 (127–162) |
RR dia (mmHg) | 84.5 (74.5–90) | 85 (80–94) |
hsCRP (mg/dl) | 0.3 (0.2–1) | 2.2 (1.1–3.8) |